000 | 01231 a2200373 4500 | ||
---|---|---|---|
005 | 20250512021823.0 | ||
264 | 0 | _c19880401 | |
008 | 198804s 0 0 eng d | ||
022 | _a0300-0664 | ||
024 | 7 |
_a10.1111/j.1365-2265.1987.tb01171.x _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aRobinson, B G | |
245 | 0 | 0 |
_aThe effect of o,p'-DDD on adrenal steroid replacement therapy requirements. _h[electronic resource] |
260 |
_bClinical endocrinology _cOct 1987 |
||
300 |
_a437-44 p. _bdigital |
||
500 | _aPublication Type: Case Reports; Journal Article | ||
650 | 0 | 4 |
_aAdrenal Gland Neoplasms _xdrug therapy |
650 | 0 | 4 |
_aAdrenal Insufficiency _xblood |
650 | 0 | 4 |
_aAdrenocorticotropic Hormone _xblood |
650 | 0 | 4 | _aAdult |
650 | 0 | 4 |
_aDexamethasone _xpharmacokinetics |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aMitotane _xadverse effects |
700 | 1 | _aHales, I B | |
700 | 1 | _aHenniker, A J | |
700 | 1 | _aHo, K | |
700 | 1 | _aLuttrell, B M | |
700 | 1 | _aSmee, I R | |
700 | 1 | _aStiel, J N | |
773 | 0 |
_tClinical endocrinology _gvol. 27 _gno. 4 _gp. 437-44 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1111/j.1365-2265.1987.tb01171.x _zAvailable from publisher's website |
999 |
_c2835926 _d2835926 |